Free Trial

This company has been marked as potentially delisted and may not be actively trading.

NASDAQ:PRXL

PAREXEL International (PRXL) Stock Price, News & Analysis

PAREXEL International logo

About PAREXEL International Stock (NASDAQ:PRXL)

Advanced Chart

Key Stats

Today's Range
$88.08
$88.08
50-Day Range
$88.08
$88.08
52-Week Range
$51.16
$88.10
Volume
N/A
Average Volume
1.04 million shs
Market Capitalization
N/A
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
N/A
Consensus Rating
N/A

Company Overview

PAREXEL International Corporation (PAREXEL) is a biopharmaceutical outsourcing services company. The Company provides a range of expertise in clinical research, clinical logistics, medical communications, consulting, commercialization, and technology products and services to pharmaceutical, biotechnology and medical device industries. Its segments include Clinical Research Services (CRS), PAREXEL Consulting Services (PC) and PAREXEL Informatics (PI). The CRS segment includes various phases of clinical research from first-in-man trials, where a medicinal entity is tested on human subjects for the first time, through post-marketing studies, following approval by the presiding regulatory body. The PC segment provides technical expertise and advice in areas, such as strategy, drug development, regulatory affairs, strategic compliance and targeted communications services in support of product launch. The Company's PI segment provides information technology solutions.

Receive PRXL Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for PAREXEL International and its competitors with MarketBeat's FREE daily newsletter.

PRXL Stock News Headlines

Parexel Strengthens Real World Research Offering
Buffett’s favorite chart just hit 209% – here’s what that means for gold
A Historic Gold Announcement Is About to Rock Wall Street For months, sharp-eyed analysts have watched the quiet buildup behind the scenes. Now, in just days, the floodgates are set to open. The greatest investor of all time is about to validate what Garrett Goggin has been saying for months: Gold is entering a once-in-a-generation mania. Front-running Buffett has never been more urgent — and four tiny miners could be your ticket to 100X gains.
Parexel Announces Updates to Board of Directors
See More Headlines

PRXL Stock Analysis - Frequently Asked Questions

Based on aggregate information from My MarketBeat watchlists, some other companies that PAREXEL International investors own include Bristol-Myers Squibb (BMY), Meta Platforms (META), ICON Public (ICLR), Universal Display (OLED), Allergan (AGN), Baidu (BIDU) and Gilead Sciences (GILD).

Industry, Sector and Symbol

Stock Exchange
NASDAQ
Sector
N/A
Industry
N/A
Sub-Industry
Life Sciences Tools & Services
Current Symbol
NASDAQ:PRXL
Fax
N/A
Employees
N/A
Year Founded
N/A

Profitability

Trailing P/E Ratio
N/A
Forward P/E Ratio
N/A
P/E Growth
N/A
Pretax Margin
N/A

Debt

Sales & Book Value

Annual Sales
N/A
Price / Cash Flow
N/A
Price / Book
N/A

Miscellaneous

Free Float
N/A
Optionable
Not Optionable
Beta
N/A
The 10 Best AI Stocks to Own in 2025 Cover

Wondering where to start (or end) with AI stocks? These 10 simple stocks can help investors build long-term wealth as artificial intelligence continues to grow into the future.

Get This Free Report

This page (NASDAQ:PRXL) was last updated on 5/8/2025 by MarketBeat.com Staff
From Our Partners